Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy

Clinical Nuclear Medicine

Volumn 34, Issue 10, 2009, Pages 651-655

  Thomas, Damita L ^a   Bartel, Twyla ^a   Menda, Yusuf ^a   Howe, James ^a   Graham, Michael M ^a   Juweid, Malik E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Parathyroid scintigraphy; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PARATHYROID ADENOMA; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID GLANDS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70349754693     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181b591c9     Document Type: Article

References (23)

1. Bringhurst F, Demay M, Kronenberg H. Hormones and disorders of mineral metabolism In: Kronenberg HM, S Melmed, KS Polonsky, et al, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier; 2008:Chapter 27.
2. Nguyen B. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy. Radiographics. 1999;19:601-614.
3. Picard, D'Amour, Carrier L, Chartrand R, et al. Localization of abnormal parathyroid gland (s) using thallium-210/iodine -123 subtraction scintigraphy in patients with primary hyperparathyroidism. Clin Nucl Med. 1987;12:60-64. (Pubitemid 17003664)
4. Hauty M, Swartz K, McClung M, et al. Technetium thallium scintigraphy for localization of parathyroid adenomas and hyperplasia: a reappraisal. Am J Surg. 1987;153:479-486. (Pubitemid 17102217)
5. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m sestamibi (double-phase study). J Nucl Med. 1992;33:1801-1807.
6. O'Doherty, Kettle AG, Wells P, et al. Parathyroid imaging with technetium 99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;22:313-318.
7. Neumann DR, Esselstyn CB Jr, Go RT, et al. Comparison of double-phase Tc99m sestamibi subtraction SPECT in hyperparathyroidism. AJR. 1997;169: 1671-1674.
8. Moka D, Voth E, Dietlein M, et al. Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery. 2000;128:29-35. (Pubitemid 30456892)
9. Billotey C, Sarfati E, Aurengo A, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med. 1996;37:1773-1778. (Pubitemid 26378360)
10. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med. 2005;30:1-3. (Pubitemid 40039571)
11. Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084-1089. (Pubitemid 47052646)
12. Lorberboym M, Minski I, Macadziob S, et al. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med. 2003;44:904-908. (Pubitemid 39663401)
13. Sharma J, Mazzaglia P, Milas M, et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality? Surgery. 2006;140:856-865 (Pubitemid 44937383)
14. SNM Procedure Guidelines for Parathyroid Scintigraphy. Available at www. SNM.org/PracticeManagement/ProcedureGuidelines.
15. Taillefer R. Parathyroid scintigraphy. In: Khalkhali I, Maublant JC, Goldsmith SJ, eds. Nuclear Oncology Diagnosis and Therapy. Philadelphia, PA: Lippincott, Williams, and Wilkins;2001:222-236.
16. Blanco I, Carril JM, Banzo I, et al. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism. Clin Nucl Med. 1998;23:291-297. (Pubitemid 28201730)
17. Arveschoug AK, Bertelsen H, Vammen B. Presurgical localization of abnormal parathyroid glands using a single injection of Tc-99m sestamibi: comparison of high-resolution parallel-hole and pinhole collimators, and interobserver and intraobserver variation. Clin Nucl Med. 2002;27:249-254. (Pubitemid 34245932)
18. Piga M, Bolasco P, Satta L, et al. Double-phase parathyroid technetium-99m- MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med. 1996;37:565-569. (Pubitemid 126618441)
19. Malhotra A, Silver CE, Deshpande V, et al. Preoperative parathyroid localization with sestamibi. Am J Surg. 1996;172:637-640.
20. Bartel T, Juweid M, Howe J, et al. Accuracy of dual-phase Tc-99m-MIBI (DPMIBI) in determining the appropriateness of unilateral neck dissection prior to first neck exploration in patients with primary hyperparathyroidism. J Nucl Med. 2003;44:145P.
21. Kao A, Shiau YC, Tsai SC, et al. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med. 2002;29:1012-1015. (Pubitemid 44298182)
22. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med. 1998;39:1441-1444. (Pubitemid 28373573)
23. Sun SS, Shiau YC, Lin CC, et al. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings. Nucl Med Biol. 2001;28:929-933.